As we continue celebrating our milestone 40th anniversary, the Alliance for Aging Research is setting its sights on another big event, Heroes in Health.

If you’re new to the show or unfamiliar with our awards dinner, it’s an annual gathering in Washington, DC where advocates, experts, patients, policymakers, clinicians, and more come together to honor leaders advancing healthy aging. And this year feels especially meaningful.

Joining us to share what we have in store is Alliance Development Coordinator, Lauren Belsky. Since joining the Alliance last year, Lauren has hit the ground running, playing a key role in corporate partnerships, fundraising

Alzheimer’s and related diseases don’t just affect memory. They also bring behavioral and psychological challenges known as neuropsychiatric symptoms, or NPS. These can include anxiety, depression, agitation, and sleep disturbances, making life difficult for both patients and caregivers. As symptoms progress, so do the risks of injury, isolation, and the need for institutional care, often worsened by stigma and limited support.

To address this, the Alliance for Aging Research and the National Alliance for Caregiving co-hosted the “Caring Together” summit in December 2025, bringing together experts, caregivers, and people with lived experience to share practical tools and strategies—now captured in a new white paper. Joining us today to discuss these resources is Jason Resendez, President and CEO of the National Alliance for Caregiving, where he leads efforts to better support more than 63 million family caregivers nationwide.

This year marks a major milestone as the Alliance for Aging Research celebrates its 40th anniversary. That’s four decades of changing the narrative around aging and fighting for equitable access to care. And if you thought turning 40 was a sign to slow down, we’re here to tell you we’re just getting started.

On this very special episode of The Check-Up, I’m joined by Alliance President and CEO Sue Peschin and Founder and Board Member Dan Perry to reflect on 40 years of service to the aging community, and to discuss our continued commitment to healthy aging.

Heart Valve Disease Awareness Day (HVDAD) takes place each February 22 during American Heart Month and was launched to raise awareness of valve disease risks and symptoms, improving detection and treatment. Before the campaign began, symptoms were often dismissed as “normal aging,” when we now know they’re not.

Today, HVDAD unites more than 135 partners including nonprofits, advocacy groups, hospitals, and heart centers to amplify awareness nationwide. We’re joined by Lindsay Clarke, COO and Senior Vice President of Health Education at the Alliance, who founded HVDAD and helped grow it into the movement it is today.

From multivitamins to protein powders, thousands of supplements crowd drugstore shelves offering over-the-counter answers to our nutritional needs. Yet with so many options out there, how do we know which ones to trust?
Joining us is US Pharmacopeia (USP), an organization focused on building trust in the supply of safe, trusted quality medicine. USP, is an independent, scientific nonprofit organization focused on building trust in the supply of safe medicines. Through rigorous science and the public quality standards they set, USP helps protect patient safety and improve the health of people around the world.

2025 has been a challenging year for advocates fighting for equitable access to care, as the CDC’s Advisory Committee on Immunization Practices has upended a legacy of science-based recommendations supported by the research community. In a particularly concerning move, ACIP removed its decades-long recommendation for the proven pediatric hepatitis B vaccine—a decision that puts millions of children at risk of long-term complications from this infectious disease.

Joining us to discuss the implications of ACIP’s latest action, and how advocacy organizations across the country are responding, is Scott Frey, Senior VP of Public Policy and Relations here at the Alliance.

Equitable access to treatment is vital for older adults with Alzheimer’s and other neurodegenerative diseases, especially in long-term care. CMS’s Long-Stay Antipsychotic Medication quality measure aimed to curb inappropriate use in nursing homes, but it has also led to unintended consequences, limiting safe, effective treatment options for more than 3 million residents.

A new Manatt Health report, supported by the Alliance’s Project PAUSE Coalition, explores these impacts and offers recommendations to restore equitable care. Joining us to discuss the findings are Chad Worz, CEO of the American Society of Consultant Pharmacists and Project PAUSE convener, and geriatric psychiatrist Dr. Amita Patel.

Open Enrollment season is here, and millions of Americans are hoping the latest formulary changes will help ease costs at the pharmacy counter. This month, the Alliance released several new resources, including an educational film, to help Medicare Part D beneficiaries make informed decisions for 2026.

Today, I’m joined by Adina Lasser, the Alliance’s Director of Public Policy and Government Relations, to discuss these new resources and break down what you need to know for this fall’s Medicare Open Enrollment, which runs from October 15 through December 7.